NCT06424327招募中不适用
Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 600
- 试验地点
- 20
- 主要终点
- Determine 3-year disease-free survival/DFS among patients undergoing pulmonary segmentectomy for lung cancer.
研究概览
简要总结
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥18 years
- •Patients suitable for segmentectomy, according to the treating surgeon
- •Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology
排除标准
- •Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years
- •History of chemotherapy or radiation therapy for a previous lung cancer
- •Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery
- •Carcinoid tumors
- •History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix
- •Actively receiving treatment for other malignancies
- •Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis.
- •Multi-segmental resection from the same lobe is not a criterion for exclusion.
研究组 & 干预措施
Participants with Lung Cancer
Participants undergoing planned pulmonary segmentectomy for primary lung cancer
干预措施: Patient-Reported Outcomes Measurement Information System (Other)
结局指标
主要结局
Determine 3-year disease-free survival/DFS among patients undergoing pulmonary segmentectomy for lung cancer.
时间窗: 3 years
DFS is measured from the date of surgery to the date of recurrence or death
Determine 5-year disease-free survival/DFS among patients undergoing pulmonary segmentectomy for lung cancer.
时间窗: 5 years
DFS is measured from the date of surgery to the date of recurrence or death
次要结局
未报告次要终点
研究者
研究点 (20)
Loading locations...
相似试验
已完成
不适用
Prospective observational results of pulmonary resection for over 75 years-old patients with non-small cell lung cancer - Multi-institutional study in Japanon-small cell lung cancerJPRN-UMIN000021904Dept. General Thoracic Surgery, National Hospital Organization Beppu Medical Center275
已完成
不适用
Survey on Lung Cancer Patient' Experience and Awareness of Precision Medicineung CancerJPRN-UMIN000048933Medical Affairs, Japan Oncology Business Uni, Takeda Pharmaceutical Company Limited.200
已完成
不适用
Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019COVID-19HemoptysisLung TBLung CancerNCT05513248Lung Center of the Philippines16
招募中
不适用
Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung CancerEarly Stage Lung Cancer (I and II)Non-Small Cell Lung CancerNCT06737107Scientific Institute San Raffaele472
Unknown
不适用
Study to Assess the Effectiveness of Transcollation Technology to Reduce Bleeding in Lung SurgeryBlood Loss, SurgicalNCT02631889University of Roma La Sapienza170